American Society of Retina Specialists (ASRS) 2022
MOSAIC: A Qualitative Study of the Clinical, Humanistic, and Financial Burden of Geographic Atrophy (GA) Among Patients and Caregivers
Detailed Baseline Demographics and Disease Characteristics of Patients with Geographic Atrophy Enrolled in the Phase 3 OAKS and DERBY Clinical Trials…and Why it Matters!
Assessment of Geographic Atrophy Lesion Progression in the Phase 3 DERBY and OAKS Trials
Retrospective Real-World Analysis of Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration Followed up for 3 Years
Characterizing Real-World Functional Outcomes in Patients With Geographic Atrophy: An IRIS Registry Analysis
Relationship Between Number of Intermediate/Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the DERBY, OAKS, and FILLY Trials
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.